Y85-23774-79467

2 vaccinations 6 coded responses 18 check-ins 6 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 165 / PA
Registered: 2021-02-04

Relationship: Self
Race: White
Ethnicity: N/A

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-04
Registered in v-safe
2021-02-04
Dose 1 — Pfizer-BioNTech
2021-02-04
Survey response — day 0, dose 1
MedDRA: Injection site pain — Feeling: Good · Site: Swelling

Free text: muscle pain at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Nausea — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness

Free text: Dizziness and nausea yesterday after reporting

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-06
Survey response — days 1–6 daily, dose 1
MedDRA: Condition aggravated, Headache, Migraine, Pre-existing disease — Feeling: Fair · Headache · Be unable to work

Free text: I have chronic migraines and IIH and had a persistent headache post injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-10
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · None

Adult check-in
2021-02-11
Health check-in — day 7, dose 1
Feeling: Fair · None

Adult check-in
2021-02-21
Survey response — day 14, dose 1
MedDRA: Loss of consciousness, Office visit — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Symptoms: Loss of conciousnes · Healthcare visit (other): Neurology

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-21
Report sent to call center — day 14, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-25
Dose 2 — Pfizer-BioNTech
2021-02-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Vomiting, Abdominal pain

Adult check-in
2021-03-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — day 7, dose 2
Feeling: Fair · None

Adult check-in
2021-03-21
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-27
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-03
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-10
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-27
Survey response — 3 months, dose 2
MedDRA: Condition aggravated, Office visit, Papilloedema, Pre-existing disease, Seizure — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Symptoms: Papilledema, progression of Intracranial Hypertension, seizures · Healthcare visit (other): Opthamologist, Neurologist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-27
Report sent to call center — 3 months, dose 2
Be unable to work · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-17
Call successful
Does not wish to fill out VAERS report
2021-08-27
Survey response — 6 months, dose 2
MedDRA: Idiopathic intracranial hypertension, Office visit, Photopsia, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Visual disturbance, flashes of light in visual field related to idiopathic intracranial hypertension · Healthcare visit (other): Neurology /radiology/opthamology

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-27
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-31
Call 1 — Could Not Reach Participant
2021-09-03
Call 2 — Could Not Reach Participant
2022-02-25
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-04	Pfizer-BioNTech
2	2021-02-25	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-02-21	Successful	Does not wish to fill out VAERS report
2021-05-27	Successful 2021-08-17	Does not wish to fill out VAERS report
2021-08-27	Unsuccessful

Free text

Release 3 — day 0, dose 1

2021-02-04

Systemic reaction (other): muscle pain at injection site

Release 3 — days 1–6 daily, dose 1

2021-02-05

Systemic reaction (other): Dizziness and nausea yesterday after reporting

2021-02-06

Systemic reaction (other): I have chronic migraines and IIH and had a persistent headache post injection

Release 4 — day 14, dose 1

2021-02-21

Symptoms: Loss of conciousnes

Healthcare visit (other): Neurology

Release 8 — 3 months, dose 2

2021-05-27

Symptoms: Papilledema, progression of Intracranial Hypertension, seizures

Healthcare visit (other): Opthamologist, Neurologist

Release 9 — 6 months, dose 2

2021-08-27

Symptoms: Visual disturbance, flashes of light in visual field related to idiopathic intracranial hypertension

Healthcare visit (other): Neurology /radiology/opthamology

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Condition aggravated	✓	✓	✓
SD	Idiopathic intracranial hypertension	✓	·	✓
SD	Loss of consciousness	✓	✓	✓
SD	Papilloedema	✓	✓	✓
SD	Photopsia	✓	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Seizure	✓	✓	✓
SD	Visual impairment	✓	·	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Migraine	✓	✓	✓
SRO	Nausea	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release